4-1BBL/IL-12-armed oncolytic vaccinia virus therapy (Bavarian Nordic/Affimed)

N/A

Report date: 2025/06/11 10:27:40

Base Information

Drug Name4-1BBL/IL-12-armed oncolytic vaccinia virus therapy (Bavarian Nordic/Affimed)
Drug Alias NameMVA-Gp70-4-1BBL-IL124-1BB costimulatory/IL-12 agonist (Bavarian Nordic/Affimed)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsImmunostimulantsT lymphocytes stimulants +[4] 
TargetsInterleukin-12 receptorTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesAffimed Nv
Inactive CompaniesBavarian Nordic A/S
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A